While it began as a revolutionary research tool a decade ago, NGS is now the method of choice for simultaneous genomic profiling of multiple cancer markers. For hospitals, the advantages of NGS over traditional methods are indisputable in terms of time savings, tissue perservation, and a precision oncology approach to patient care.
With NGS testing in-house, you no longer have to give up your samples and rely on outside labs, which can take weeks and potentially lead to high failure rates. With your sample and testing expertise onsite, your multidisciplinary team is always empowered with the information they need to tailor patient treatments for better outcomes.
Get our educational guide and learn:
Now any hospital pathology lab can perform NGS. A highly automated workflow makes it easy for you to get started with your existing staff and infrastructure. Intuitive reporting enables you to deliver the results that capture critical information and links biomarkers to relevant evidence.
As your hospital's needs evolve, your flexible NGS platform easily adapts to meet new demands for different types of assays.
One Platform. Multiple Applications.
While the idea of adopting NGS may seem overwhelming, we're confident that you'll find the NGS implementation process much easier than you might think. Our NGS consultants are there every step of the way - from providing analytical assay validation services to creating a CLIA validated offering. You'll be NGS proficient and efficient before you know it.
Learn how NGS can complement your existing laboratory workflows, while providing a powerful new approach for rapidly generating comprehensive molecular data. Hear the speakers’ own perspectives and insights on NGS applications for hemato-oncology, including DNA and RNA profiling using gene panels for myeloid and lymphoid malignancies, as well as immune repertoire sequencing for clonality assessment, MRD detection, and somatic hypermutation analysis of lymphoid samples.
In this CAP Today webinar, you'll learn how to keep pace with the fast-changing guidelines in precision oncology, test the most challenging samples, and optimize outcomes for as many NSCLC patients as possible.
See how University Hospital Basel is using NGS testing to inform treatment decisions for lung cancer patients.